Biotech: Page 35
-
Hidden Talents
Hidden Talents What are their hidden talents? Our honorees have and share a multitude of talents. They are creative, innovative, encouraging, visionary, engaging, etc. But they also have some lesser known abilities that make them uniquely them. Dr. Dan Baker throws a mean curveball. Dr. Scott C...
By Taren Grom • July 29, 2013 -
Reading List
Reading List What are they reading? The PharmaVOICE 100 are constant learners and are tapping into new and time-tested books on a variety subjects, of particular note business and leadership topics. We’ve included a selection of what’s hot on their reading list. The Lean Start Up is on the read...
By Taren Grom • July 29, 2013 -
Trendline
Commercialization, marketing and social media
As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical.
By PharmaVoice staff -
Cloak of Invisibility
If they were invisible, where would they go? While several of our honorees indicated they like to be present at all times, many of our PV 100 honorees wouldn’t mind donning a cloak of invisibility in some unusual places. Andrew Burns would like to have been in the locker room to hear Herb Brooks...
By Taren Grom • July 29, 2013 -
Favorite APPs
Favorite APPs Social Media Mavens Follow and connect with the PV 100 via Twitter, LinkedIn, and Facebook to find out what they have to say about the state of healthcare. And check out the apps that keep them organized and entertained. Favorite APPLICATIONS Uber Request a private car in any city t...
By Taren Grom • July 29, 2013 -
Giving Back
The PharmaVOICE 100 honorees share a sincere desire to give back. Their philanthropic endeavors range from participation in company-based service days to providing resources and assistance to their communities, schools, and national and global organizations. Favorite charities American Cancer Soc...
By Taren Grom • July 29, 2013 -
Alternate Professions
What profession, other than theirs, would the PharmaVOICE 100 like to attempt? Not surprising, several of the honorees identified teaching as their alternate profession of choice, while others have an affinity for blogging, building, and blending art and science. Dr. Sharon Presnell would work i...
By Taren Grom • July 29, 2013 -
First Jobs
First Jobs What was their first job? We thought it would be fun to know how these highly successful executives earned their first paychecks. As it turns out, many of them got their start in business by mowing lawns, delivering papers, or working in food service. Christine Pierre ran a babysitt...
By Taren Grom • July 29, 2013 -
Place of Birth
Place of Birth Where they were born? Christine Pierre and Steve Collis were born 10,532 miles (16,945.99 kilometers) apart, but they share a global perspective on improving healthcare. Dr. Dominic Behan, Tim Davis, Jamie Heywood, Joanne Kamens, Dr. Daniel Kraft, Andrea McGonigle, Mike Rea have t...
By Taren Grom • July 29, 2013 -
The Patient Advocates
The Patient Advocates Jamie Ring Taking Advocacy to New Levels Passionate. Solution-Oriented. Witnessing the courageous actions of a high school classmate’s family in the face of leukemia clearly defined for Jamie Ring what she wanted to do with her life. The classmate was diagnosed with a rare f...
By Taren Grom • July 29, 2013 -
PharmaVOICE 100 - Who's on the List by Section
The Commanders & Chiefs David Berry Pronutria Damian Braga Sanofi Pasteur David Bruggeman Clinical Research Advantage Walter Capone The Multiple Myeloma Research Foundation Steve Collis AmerisourceBergen Corp. Nick Colucci Publicis Healthcare Communications Group Jim Curtis Remedy Health Medi...
By Taren Grom • July 29, 2013 -
Talent Pool
Talent Pool By Ann Grey Pharma Pool Dave Lemus Sigma-Tau Pharmaceuticals Names CEO Sigma-Tau Pharmaceuticals Inc. has promoted Dave Lemus to the newly created position of CEO. Mr. Lemus had served as chief operating officer of the company since March 2012 and he joined the company as VP of financ...
By Ann Grey • July 29, 2013 -
2013 PharmaVOICE 100 - Who's on the List by Company
2013 PharmaVOICE 100 – Who’s on the List by Company Indexed by Company Affiliation Accelrys Ken Rapp Acorda Therapeutics Denise Duca Acurian Kristin Gross Addgene Dr. Joanne Kamens Advanced Clinical Concepts David Rear Agano Solutions and Auditgraph Mauricha Marcussen AmerisourceBergen Corp. Stev...
By Taren Grom • July 29, 2013 -
Letter from the Editor
Letter from the Editor By Taren Grom The 2013 PharmaVOICE 100 Each year we have the privilege of showcasing 100 of the most inspiring and motivational individuals throughout the life-sciences industry. This special issue, now in its ninth year, once again showcases the individuals as identified b...
By Taren Grom • July 29, 2013 -
C-Suite: Biotechnology
C-Suite: Biotechnology By Taren Grom Innovation and technology remain key assets of the biotechnology industry, which is moving toward value-based healthcare and patient centricity. As the world marks the 60th anniversary of the publication of James Watson and Francis Crick’s landmark work on the...
By Taren Grom • May 29, 2013 -
Innovative Israel Creates Pharma Opportunity
The state of Israel is one of the most advanced economies in the southwest Asia region, and is rated 38th out of 185 nations worldwide on the World Bank’s Ease of Doing Business Index. Often described as a start-up nation, Israel hosts more NASDAQ-listed companies per citizen than any other count...
By Kim Ribbink • May 29, 2013 -
2013 DIA Preview
2013 DIA Preview This year’s theme: Advancing Therapeutic Innovation and Regulatory Science. The Drug Information Association’s 49th Annual Meeting will be held June 23 to 27 at the Boston Convention & Exhibition Center. There will be more than 250 sessions covering 22 tracks on hot topics fr...
By Taren Grom • May 29, 2013 -
Adapting to Adaptive Drug Development
The promise of cost-savings associated with adaptive clinical trials is an attractive one. Many drug companies have already put in place trials that use some type of adaptive designs. But most times, companies implement adaptive trial design experimentally, mitigating risk by applying it only dur...
By Denise Myshko • May 29, 2013 -
Talent Pool
Pharma Pool Dr. Lynn KRAMER Eisai Creates New Chief Clinical Officer Position Eisai, the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., has appointed Lynn Kramer, M.D., to the newly created position of chief clinical officer of Eisai Product Creation Systems. In this role, Dr. Kramer is respo...
By Ann Grey • May 29, 2013 -
On the Calendar
June 17-18 Gross to Net Accounting Forum for Pharmaceutical Manufacturers Hyatt Harbor Side, Boston Institute for International Research, iirusa.comJune 17-19 Next-Gen Kinase Inhibitors The Revere Hotel, Boston Cambridge Healthtech Institute, healthtech.com/kin/ June 18 5th Annual Cloud Slam 2013...
By Heather Hummel • May 29, 2013 -
What's New
New Healthcare-related Products, Services, and Companies Featured Briefs: GSW Launches Health Experience Project Teva Establishes Global Specialty Medicines Group Sidebars: On the Shelves AROUND THE GLOBE New 360 Corporate Compliance Program for the Life-Sciences Industry Weber Shandwick Launch...
By Ann Grey • May 29, 2013 -
Your Teachable Moment is Now
One of your sales organization’s biggest challenges is to develop and nurture an ongoing learning environment for field reps. Your goal is to make every rep as good as your best rep by providing tools and training that raise the playing field to its highest level. The secret lies in continuous, c...
By Jay Goldman • April 26, 2013 -
SHOWCASE FEATURE: Training: A New Way Forward
Jay Goldman Senior VP Innovation Klick Health Training in the Moment Reps need to be provided with ongoing, in-the-moment training, served up in small bite-sized snippets. These are then put into practice immediately, shortening the time gap between learning and execution and reinforcing lessons...
By Taren Grom • April 26, 2013 -
South Africa: Wealth Disparity versus Pharma Opportunity
According to Zane Wilson, founder of the South African Depression and Anxiety Group, with the recent global recession, poor households have sunk deeper into poverty and many more South Africans are finding themselves steeped in financial woes. One in five South Africans may suffer from a mental d...
By Kim Ribbink • April 26, 2013 -
Last Word
The Growing Problem of Drug Shortages John Petricciani, President of the International Alliance for Biological Standardization, discusses the causes and impact of drug shortages. FDA’s New Authority Over Drug Shortages On July 9, 2012, President Obama signed into law the Food and Drug Administra...
By John Petricciani • April 26, 2013 -
Talent Pool
Pharma Pool Debra BARRETT Teva Appoints New Senior VP Teva has appointed Debra Barrett as the new senior VP of global government affairs and public policy. She was previously serving in the role as senior VP of government and public affairs in the United States. Ms. Barrett has taken over the dru...
By Ann Grey • April 26, 2013